Quantum-Si (QSI) Projected to Post Earnings on Thursday

Quantum-Si (NASDAQ:QSI) is expected to issue its quarterly earnings data after the market closes on Thursday, March 6th. Analysts expect the company to announce earnings of ($0.18) per share and revenue of $1.23 million for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Quantum-Si Stock Performance

Shares of QSI opened at $1.38 on Wednesday. Quantum-Si has a fifty-two week low of $0.61 and a fifty-two week high of $5.77. The company has a market capitalization of $196.94 million, a PE ratio of -2.16 and a beta of 2.69. The stock has a fifty day moving average of $2.24 and a two-hundred day moving average of $1.45.

Insiders Place Their Bets

In other news, Director Jonathan M. Rothberg sold 3,506,267 shares of the firm’s stock in a transaction on Friday, December 27th. The shares were sold at an average price of $3.34, for a total value of $11,710,931.78. Following the transaction, the director now owns 1,250,000 shares of the company’s stock, valued at approximately $4,175,000. This trade represents a 73.72 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 30.04% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on QSI. HC Wainwright reiterated a “buy” rating and set a $5.50 target price on shares of Quantum-Si in a research report on Tuesday, January 14th. Alliance Global Partners assumed coverage on shares of Quantum-Si in a research report on Friday, February 7th. They issued a “buy” rating and a $3.75 target price on the stock. Finally, Canaccord Genuity Group lowered their target price on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, November 13th.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.